Sounding Board

You have full text access to this OnlineOpen article

Acetaminophen and the U.S. acute liver failure study group: Lowering the risks of hepatic failure

  1. William M. Lee M.D., F.A.C.P.†,*

Article first published online: 30 JUN 2004

DOI: 10.1002/hep.20293

Issue

Hepatology

Hepatology

Volume 40, Issue 1, pages 6–9, July 2004

Additional Information

How to Cite

Lee, W. M. (2004), Acetaminophen and the U.S. acute liver failure study group: Lowering the risks of hepatic failure. Hepatology, 40: 6–9. doi: 10.1002/hep.20293

Author Information

  1. Division of Digestive and Liver Diseases, University of Texas, Southwestern Medical Center, Dallas, TX

  1. †

    fax: 214-648-3715

*Division of Digestive and Liver Diseases, University of Texas, Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9151

Publication History

  1. Issue published online: 30 JUN 2004
  2. Article first published online: 30 JUN 2004
  3. Manuscript Accepted: 27 APR 2004
  4. Manuscript Received: 22 FEB 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (77K)

References

  • 1
    Proceedings of the FDA NDAC meeting, September 19, 2002. Testimony of Parivash Nourjah, Ph.D. Available at: www.fda.gov/ohrms/dockets/ac/cder02.htm#NonprescriptionDrugs. Accessed: April 15, 2004.
  • 2
    Lee WM. Acute liver failure in the United States. Semin Liv Dis 2003; 23: 217–226.
  • 3
    Ives N. By reconsidering its message and its mission, the maker of Tylenol practices what it preaches. New York Times, March 17, 2004: C8.
  • 4
    Proceedings of the FDA NDAC meeting, Introduction by Charles E. Ganley, MD www.fda.gov/ohrms/dockets/ac/cder02.htm#NonprescriptionDrugs. Accessed: April 15, 2004.
  • 5
    Seeff LB, Cuccherini BA, Zimmerman HJ, Adler E, Benjamin SB. Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Intern Med 1986; 104: 399–404.
  • 6
    Zimmerman HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. HEPATOLOGY 1995; 22: 767–773.
    Direct Link:
  • 7
    Schiødt FV, Atillasoy E, Shakil O, Lee WM, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999; 5: 29–34.
    Direct Link:
  • 8
    Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6: 163–169.
  • 9
    Ostapowicz GA, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SBH, et al., and the Acute Liver Failure Study Group Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 945–954.
  • 10
    Schiødt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997; 337: 1112–1117.
  • 11
    Shayiq RM, Roberts DW, Rothstein K, Snawder JE, Benson W, Ma X, et al. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury. HEPATOLOGY 1999; 29: 451–463.
    Direct Link:
  • 12
    Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994; 272: 1845–1850.
  • 13
    Makin AJ, Williams R. Acetaminophen-induced hepatotoxicity: predisposing factors and treatments. Adv Intern Med 1997; 42: 453–483.
  • 14
    Davern TJ, James L, Larson A, Fontana R, Polson J, Lalani E, et al., and the U.S ALF Study Group. Serum acetaminophen adducts identify patients with severe acetaminophen toxicity [abstract]. HEPATOLOGY 2003; 34: 539A.
  • 15
    Polson J, Ocama P, Larson AM, Hynan L, Lalani E, Harrison M, et al., and the U.S ALF Study Group. Role of acetaminophen in acute liver failure due to viral hepatitis [abstract]. HEPATOLOGY 2003; 34: 544A.
  • 16
    Rezende G, Roque-Afonso AM, Samuel D, Gigou M, Nicand E, Ferre V, et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. HEPATOLOGY 2003; 38: 613–618.
    Direct Link:
  • 17
    Makin AJ, Wendon J, Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 1995; 109: 1907–1916.
  • 18
    Bernal W. Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liver Dis 2003; 23: 227–237.
  • 19
    Hawton K, Townsend E, Deeks J, Simpson KJ, MacDonald TM. Effects of legislation restricting packsizes of paracetamol and salicylate poisoning in the United Kingdom before and after stud. BMJ 2001; 322: 1203–1207.
  • 20
    Sheen C, Dillon J, Bateman D, Appleby L, Ginneli D, Bennewith O, et al. Paracetamol pack size restriction: the impact on paracetamol poisoning and over-the-counter supply of paracetamol, aspirin and ibuprofen. Pharmacoepidemiol Drug Saf 2002; 11: 329–331.
    Direct Link:
  • 21
    Robinson D, Smith A, Johnston G, et al. Severity of overdose after restriction of paracetamol availability: retrospective study. BMJ 2000: 321: 926–927.
  • 22
    Moynihan R. FDA fails to reduce accessibility of paracetamol despite 450 deaths a year. BMJ 2002; 3325: 678.
View Full Article (HTML) Get PDF (77K)